Octave Accelerates Leadership in Precision Care with Addition of World-Class Commercial Executives More

News & Blog

Catch the latest

Recent Announcements & Press

Octave® Bioscience, Inc. Announces Chairman of the Board, CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for its Precision Care Solution

Octave® Bioscience, Inc. Receives $10 Million Grant from The Michael J. Fox Foundation to Develop and Validate Multi-Analyte Protein Biomarker Test for Parkinson’s Disease Assessments – Businesswire

Octave®Bioscience, Inc. Gaining Traction Among Clinicians for Proteomic Multiple Sclerosis Test – GeonomeWeb

Octave Note

Leveraging Biology for Better Informed Treatment Decisions

Precision Medicine: Biomarkers as an Objective Measure

Octave at ECTRIMS: An Overview of Scientific Research Presented on Our MS Precision Care Solution

Media Library

living well

Being Diagnosed with Multiple Sclerosis

living well

Earliest Stages of Multiple Sclerosis

living well

Is My MS Controlled?